Home › Mylan begins marketing HIV treatment
 

Keywords :   


Mylan begins marketing HIV treatment

2015-01-16 18:27:04| Biotech - Topix.net

Canonsburg-based generic drug maker Mylan Inc. has begun marketing a medication that is used to treat hepatitis B and the human immunodeficiency virus. Mylan's 100-mg lamivudine tablets are a generic version of GlaxoSmithKline's Epivir-HBV, a medication approved in 1995 by the Food & Drug Administration.

Tags: marketing treatment begins hiv

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »